US Patent 11191849 Compositions and methods for delivering messenger RNA
Patent 11191849 was granted and assigned to Arbutus Biopharma Corporation on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+364 characters)
Article
Patent abstract
The present invention provides compositions comprising nucleic acid molecules, such as mRNA molecules, encapsulated within lipid particles. The compositions are useful, for example, to introduce the mRNA molecules into a human subject where they are translated to produce a polypeptide that functions to ameliorate one or more symptoms of a disease.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Adam Judge0
Edward D. Yaworski0
James Heyes0
Kieu Mong Lam0
Lorne Ralph Palmer0
Michael J. Abrams0
Stephen P. Reid0
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111918490
Date of Patent
December 7, 2021
0Patent Application Number
163121620
Date Filed
June 30, 2017
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11191849 Compositions and methods for delivering messenger RNA
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11191849
Date of patent
December 7, 2021
Patent application number
16312162
Date Filed
June 30, 2017
Patent primary examiner
Find more entities like US Patent 11191849 Compositions and methods for delivering messenger RNA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.